Stockreport

Cognition Therapeutics to Participate in Upcoming September 2024 Investor Conferences

Cognition Therapeutics, Inc.  (CGTX) 
PDF PURCHASE, N.Y., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drug [Read more]